2-Pyrazolines (4,5-dihydro-1H-pyrazole) are an important class of five-membered heterocyclic compounds and were found to be vital building block in medicinal chemistry and led to the discovery of a number of bioactive derivatives. The recent significant anticonvulsant and MAO inhibitory bioactivities of a variety of 2-pyrazolines are reviewed and discussed.
appreciable anticonvulsant activity, reflected by its ability to afford protection against PTZ-induced seizures in mice . 
1
In a further work in Parmer group by Singh et al. In 1974, several 3-(3-acetoamino) phenyl-1,5-substituted-2-pyrazolines have been prepared. All substituted pyrazolines exhibited anticonvulsant activity, which was reflected by 30-80% protection observed against pentylenetetrazole-induced seizures. Compound 2 showed the highest protection (80%) at 100 mg/kg (Singh 1974 (Pandey 1979) have prepared a series of 1,3-disubstituted-5-(2-arylindol-3-yl)-2-pyrazolines. The new compounds at a dose of 100 mg/kg i.p. had anticonvulsant activity in mice. The degree of protection against PTZ-induced convulsions was 10-60%. Compound 3 was the most active compound. 
3
The single study in the eighties has been performed by Soni et al. in 1987 . They have synthesized a series of 1,5-diaryl substituted-3-(4-chloro phenyl)-2-pyrazoline in which compound 4 provided 20-80% protection at 100 mg/kg against PTZ-induced convulsions in mice with low neurotoxicity (LD 50 500-1000 mg/kg) (Soni 1987) . 
5
In the second study (Archana 2002), a series of 1-acetyl-5-aryl-3-(2'-oxo/thiobarbiturinyl)-2-pyrazolines has been synthesized. The synthesized compounds showed anticonvulsant activity ranging from 40 % to 90 %. Compound 6 showed the maximum activity being more potent than the reference drug. Another series of novel benzoxazole and benzimidazole pyrazolines has been prepared by Pujar et al. in 2008 and screened for in vivo anticonvulsant activity by PTZ induced convulsion in albino mice using diazepam as standard. Among tested compounds, compound 8 exhibited significant anticonvulsant effect (Pujar 2008) . The preliminary results showed that all of the tested compounds were protective against MES at 100-300 mg/kg dose levels. Compound 9 was the most protective against MES even at 30 mg/kg dose levels (Siddiqui 2010) . 
Pyrazolines with monoamine oxidase inhibitory activity:
Inhibitors of monoamine oxidase have shown therapeutic value in a variety of neurodegenerative diseases (Youdim 2006) . The discovery in the 1950s of the antidepressant properties of MAO inhibitors (MAOIs) was the major finding that led to the monoamine theory of depression. Earlier MAO inhibitors introduced into clinical practice for the treatment of depression were abandoned due to adverse side-effects, such as hepatotoxicity, orthostatic hypotension and the so-called 'cheese effect' characterized by hypertensive crises (Coutts 1986 ). This handicap was thought to be related to nonselective and irreversible monoamine oxidase inhibition. However, more recently, a better knowledge of the enzyme, in particular the identification of two isoforms (MAO-A and MAO-B) that can be selectively inhibited and the development of new generations of inhibitors have led to a renewed interest in the therapeutic potential of these compounds. These two forms of MAO are characterized by their different sensitivities to inhibitors and their different specificities to substrates. MAO-A preferably metabolizes serotonin, adrenaline, and noradrenaline (Johston 1968) , whereas ß-phenylethylamine and benzylamine are predominantly metabolized by MAO-B. Tyramine, dopamine, and some other important amines are common substrates for both isoenzymes. Nowadays, the therapeutic interest of MAOIs falls into two major categories. MAO-A inhibitors have been used mostly in the treatment of mental disorders, in particular depression and anxiety (Pacher 2004) , while MAO-B inhibitors could be used in the treatment of Parkinson's disease and perhaps, Alzheimer's disease (Wouters 1998) .
Studies by Parmar et al. and Soni et al. representing monoamine oxidase inhibitory activities of some 1,3,5-triphenyl-2-pyrazolines act as impetus for further research in this field ) (Soni 1987) . Thus, two series of 2-pyrazolines have been introduced by Palaska et al. in the first study, ten new 1,3,5-triphenyl-2-pyrazolines have been synthesized and evaluated for their antidepressant activities using 'Behavioural Despair Test'. Compound 11 reduced immobility time by 49.51% at 100 mg kg −1 (Palaska 1996) .
OCH 3 11 In the second study, a series of 3,5-diphenyl-2-pyrazolines has been synthesized. The antidepressant activities of the synthesized compounds were evaluated by the 'Porsolt Behavioural Despair Test' where compound 12 showed the best activity and reduced immobility time by 48.62 % at 100 mg kg −1 (Palaska 2001 Cl 12 Further 1,3,5-tri-substituted 2-pyrazolines have been introduced by Prasad et al. Therefore, series of 3-(2-Naphthalen-1-yl)-1,5-diphenyl-2-pyrazolines has been prepared and evaluated by the Porsolt behavioural despair test. Compound 13 was the most active candidate showing 54.10 % reduction in the immobility time at 100 mg/kg (Prasad 2005) . (14) and 1-thiocarbamoyl-3-(4-methoxyphenyl)-5-(2-chloro-3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole (15) were found as potent as clorgyline (Palaska 2008) . 
15
Utilizing the multifunctional nature of pyrazolines with hydroxylphenyl substitution in 3rd and 5th position as metal chelating agents with antioxidant activity which are requirements in MOA-B selective inhibitors , Jayaprakash et al have tested series of 3,5-Diaryl carbothioamide pyrazolines against two isoforms of rat liver MAO-A and MAO-B. Compound 16 was found to be selective inhibitors of rat liver MAO-B (IC 50 : 37.0 ± 3.05 µM) (Jayaprakash 2008) . (Maccioni 2010) .
In the same vein, eight new 1-[(N,N-disubstituted thiocarbamoylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazolines have been synthesized and their antidepressant-like activity was investigated in mouse forced swimming test (FST). Compound 23 was found to be more effective in FST at 100mg/kg than clomipramine and tranylcypromine used as reference antidepressant drugs (Gok 2010) . 
23
A hybrid series of the antidepressants triazoles and pyrazolines has been synthesized by Kaplancıklı et al. and investigated their potential antidepressant activities using both modified forced swimming and tail suspension tests. Compound 24 displayed the best activity being more active than Fluoxetine at 100 mg/kg (Kaplancıklı 2010) . 
